TrialScientific reports2021
Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer.
Kristi Krüger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it